Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zachary Sandusky"'
Autor:
Albert Grinshpun, Douglas Russo, Wen Ma, Ana Verma, Francisco Hermida-Prado, Shira Sherman, Giorgio Gaglia, Sheheryar Kabraji, Gregory Kirkner, Melissa E. Hughes, Nancy U. Lin, Zachary Sandusky, Agostina Nardone, Cristina Guarducci, Quang-De Nguyen, Sandro Santagata, Zsuzsanna Nagy, Rinath Jeselsohn
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract The ESR1 ligand binding domain activating mutations are the most prevalent genetic mechanism of acquired endocrine resistance in metastatic hormone receptor-positive breast cancer. These mutations confer endocrine resistance that remains est
Externí odkaz:
https://doaj.org/article/7c7a103652a4404eac1f649798184d56
Autor:
Delia Margaret Friel, Zachary Sandusky, Yijia Jiang, Xintao Qiu, Rong Li, Henry Long, Rinath Jeselsohn, Myles Brown
Publikováno v:
Cancer Research. 83:3875-3875
Estrogen receptor alpha (ER) is a ligand activated transcription factor and a driver of ER+ breast cancer. The discovery of activating mutations in ER (gene name ESR1), in patients with advanced endocrine-resistant ER+ breast cancer, has ignited a la
Autor:
Zachary Sandusky
Publikováno v:
Cancer Research. 82:4033-4033
Targeted protein degradation (TPD) is a new pharmaceutical strategy to hijack the ubiquitin-proteasome system to degrade target proteins. Many TPD drugs are discovered serendipitously, and we are only beginning to harness their potential. Understandi
Autor:
Grinshpun, Albert, Russo, Douglas, Ma, Wen, Verma, Ana, Hermida-Prado, Francisco, Sherman, Shira, Gaglia, Giorgio, Kabraji, Sheheryar, Kirkner, Gregory, Hughes, Melissa E., Lin, Nancy U., Sandusky, Zachary, Nardone, Agostina, Guarducci, Cristina, Nguyen, Quang-De, Santagata, Sandro, Nagy, Zsuzsanna, Jeselsohn, Rinath
Publikováno v:
NPJ Breast Cancer; 6/8/2024, Vol. 10 Issue 1, p1-12, 12p
Publikováno v:
Women's Health Weekly; 6/25/2024, p267-267, 1p